In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 61090-37-7, name is 2,3-Dihydrobenzofuran-4-amine, introducing its new discovery. Recommanded Product: 61090-37-7
There are provided according to the invention novel compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof: (I) wherein: R1 is phenyl which may be unsubstituted or substituted by one or two substituents selected from fluorine, chlorine, C1-2alkoxy-, -CN; phenyl fused to a 5-membered saturated ring containing one oxygen atom; pyridinyl which may be unsubstituted or substituted by one or two substituents selected from fluorine or chlorine; or C-linked pyrazolyl which may be unsubstituted or substituted by the substituent C1-2alkyl; R2 is C1-4alkyl; R3 is C1-2alkyl; and n is 0, 1 or 2.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 61090-37-7, and how the biochemistry of the body works.Recommanded Product: 61090-37-7
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H465O – PubChem